Korean J Ophthalmol.  2012 Aug;26(4):260-264. 10.3341/kjo.2012.26.4.260.

Systemic Factors Associated with Central Serous Chorioretinopathy in Koreans

• Eom Y
• Oh J
• Kim SW
• Huh K

• KMID: 1387392
• DOI: http://doi.org/10.3341/kjo.2012.26.4.260

Abstract

PURPOSE
To investigate systemic factors associated with central serous chorioretinopathy (CSC).
METHODS
We retrospectively reviewed the medical records of 113 Korean patients who were diagnosed with CSC and who underwent history taking with a specialized questionnaire for CSC. They were matched for age and gender at a ratio of 1 : 3 to 339 normal controls. Normal controls were consecutively selected from a database at the Health Promotion Center. General characteristics and medical histories were compared between the two groups. The statistical analyses used included independent t-test, Mann-Whitney test, Fisher's exact test, and multivariate logistic regression analysis.
RESULTS
There were 90 men and 23 women in the CSC group, and the male-female ratio for both groups was 3.9 : 1. The mean age of the patients was 45.6 years. In multivariate analysis, hypertension (odds ratio [OR], 2.327; 95% confidence interval [CI], 1.349-4.013), use of medicinal plants (OR, 2.198; 95% CI, 1.193-4.049), sleep disturbances (OR, 1.732; 95% CI, 1.096-2.739), and snoring (OR, 1.727; 95% CI, 1.058-2.820) were strongly associated with CSC.
CONCLUSIONS
Hypertension, sleep disturbance, snoring, and medicinal plant use were identified as factors associated with CSC. Expanded history taking, including systemic factors and culture-specific behavior related to stress or fatigue such as use of medicinal plants, will be helpful in identifying Korean patients at an increased risk for CSC.

Keyword

Central serous chorioretinopathy; Fatigue, Medicinal plants; Sleep; Snoring

MeSH Terms

Asian Continental Ancestry Group
Case-Control Studies
Central Serous Chorioretinopathy/*epidemiology/*etiology
Female
Humans
Logistic Models
Male
Middle Aged
Questionnaires
Republic of Korea/epidemiology
Retrospective Studies
Risk Factors
Statistics, Nonparametric

Reference

1. Gass JD. Pathogenesis of disciform detachment of the neuroepithelium. II. Idiopathic central serous choroidopathy. Am J Ophthalmol. 1967. 63:587–615.

2. Maumenee AE. Macular diseases: clinical manifestations. Trans Am Acad Ophthalmol Otolaryngol. 1965. 69:605–613.

3. Spaide RF, Hall L, Haas A, et al. Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina. 1996. 16:203–213.

4. Scheider A, Nasemann JE, Lund OE. Fluorescein and indocyanine green angiographies of central serous choroidopathy by scanning laser ophthalmoscopy. Am J Ophthalmol. 1993. 115:50–56.

5. Guyer DR, Yannuzzi LA, Slakter JS, et al. Digital indocyanine-green videoangiography of occult choroidal neovascularization. Ophthalmology. 1994. 101:1727–1735.

6. Piccolino FC, Borgia L. Central serous chorioretinopathy and indocyanine green angiography. Retina. 1994. 14:231–242.

7. Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina. 2009. 29:1469–1473.

8. Bennett G. Central serous retinopathy. Br J Ophthalmol. 1955. 39:605–618.

9. Gelber GS, Schatz H. Loss of vision due to central serous chorioretinopathy following psychological stress. Am J Psychiatry. 1987. 144:46–50.

10. Jain IS, Singh K. Maculopathy a corticosteroid side-effect. J All India Ophthalmol Soc. 1966. 14:250–252.

11. Wakakura M, Ishikawa S. Central serous chorioretinopathy complicating systemic corticosteroid treatment. Br J Ophthalmol. 1984. 68:329–331.

12. Garg SP, Dada T, Talwar D, Biswas NR. Endogenous cortisol profile in patients with central serous chorioretinopathy. Br J Ophthalmol. 1997. 81:962–964.

13. Tittl MK, Spaide RF, Wong D, et al. Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol. 1999. 128:63–68.

14. How AC, Koh AH. Angiographic characteristics of acute central serous chorioretinopathy in an Asian population. Ann Acad Med Singapore. 2006. 35:77–79.

15. Levine R, Brucker AJ, Robinson F. Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography. Ophthalmology. 1989. 96:854–859.

16. Haimovici R, Koh S, Gagnon DR, et al. Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology. 2004. 111:244–249.

17. Leveque TK, Yu L, Musch DC, et al. Central serous chorioretinopathy and risk for obstructive sleep apnea. Sleep Breath. 2007. 11:253–257.

18. Kloos P, Laube I, Thoelen A. Obstructive sleep apnea in patients with central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2008. 246:1225–1228.

19. McArdle N, Hillman D, Beilin L, Watts G. Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study. Am J Respir Crit Care Med. 2007. 175:190–195.

20. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000. 342:1378–1384.

21. Tang SY, Halliwell B. Medicinal plants and antioxidants: what do we learn from cell culture and Caenorhabditis elegans studies? Biochem Biophys Res Commun. 2010. 394:1–5.

22. Chen YY, Liu JF, Chen CM, et al. A study of the antioxidative and antimutagenic effects of Houttuynia cordata Thunb. using an oxidized frying oil-fed model. J Nutr Sci Vitaminol (Tokyo). 2003. 49:327–333.

23. Deyama T, Nishibe S, Nakazawa Y. Constituents and pharmacological effects of Eucommia and Siberian ginseng. Acta Pharmacol Sin. 2001. 22:1057–1070.

24. Yi HH, Park HA, Kang JH, et al. What types of dietary supplements are used in Korea? Data from the Korean National Health and Nutritional Examination Survey 2005. Korean J Fam Med. 2009. 30:934–943.

25. Wu Y, Zhang Y, Wu JA, et al. Effects of Erkang, a modified formulation of Chinese folk medicine Shi-Quan-Da-Bu-Tang, on mice. J Ethnopharmacol. 1998. 61:153–159.

26. Jung K, Kim IH, Han D. Effect of medicinal plant extracts on forced swimming capacity in mice. J Ethnopharmacol. 2004. 93:75–81.

27. Fraunfelder FW. Ocular side effects from herbal medicines and nutritional supplements. Am J Ophthalmol. 2004. 138:639–647.

28. Jo EH, Kim SH, Ra JC, et al. Chemopreventive properties of the ethanol extract of chinese licorice (Glycyrrhiza uralensis) root: induction of apoptosis and G1 cell cycle arrest in MCF-7 human breast cancer cells. Cancer Lett. 2005. 230:239–247.

29. Lee HK, Jung BM. An investigation of the intake of the health improving agents and health status by male workers in Chonnam Yeosu industrial area. Korean J Community Nutr. 2007. 12:569–582.

30. Choi MK, Kim JM, Kim JG. A study on the dietary habit and health of office workers in Seoul. Korean J Food Cult. 2003. 18:45–55.

31. Park J, Ha M, Yi Y, Kim Y. Subjective fatigue and stress hormone levels in urine according to duration of shiftwork. J Occup Health. 2006. 48:446–450.

32. Yoshioka H, Sugita T, Nagayoshi K. Fluorescein angiographic findings in experimental retinopathy produced by intravenous adrenaline injection. Preliminary report. Nihon Ganka Kiyo. 1970. 21:648–652.

33. Nagayoshi K. Experimental study of choroidoretinopathy by intravenous injection of adrenaline. Nihon Ganka Gakkai Zasshi. 1971. 75:1720–1727.

34. Miki T, Sunada I, Higaki T. Studies on chorioretinitis induced in rabbits by stress (repeated administration of epinephrine). Nihon Ganka Gakkai Zasshi. 1972. 76:1037–1045.

35. Yoshioka H, Katsume Y, Akune H. Experimental central serous chorioretinopathy in monkey eyes: fluorescein angiographic findings. Ophthalmologica. 1982. 185:168–178.

36. Bouzas EA, Karadimas P, Pournaras CJ. Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol. 2002. 47:431–448.

37. Carvalho-Recchia CA, Yannuzzi LA, Negrao S, et al. Corticosteroids and central serous chorioretinopathy. Ophthalmology. 2002. 109:1834–1837.

38. Haimovici R, Rumelt S, Melby J. Endocrine abnormalities in patients with central serous chorioretinopathy. Ophthalmology. 2003. 110:698–703.

39. Klais CM, Ober MD, Ciardella AP, Yannuzzl LA. Ryan SJ, editor. Central serous chorioretinopathy. Retina. 2006. 4th ed. Philadelphia: Elsevier/Mosby;1135–1161.

40. Ministry of Health and Welfare. Korea Health Statistics 2009: Korea National Health and Nutrition Examination Survey (KNHANESIV-3). 2010. Seoul: Ministry of Health and Welfare.